Spire Healthcare shares gained modestly today after two company-specific developments shifted investor attention away from a cautious mid-cap market. Toscafund Asset Management - which holds an 18% stake and is the group's second-largest shareholder - has been granted a third extension to submit a formal takeover offer, moving the "put up or shut up" deadline to August 6, 2026 from what had been today's original cut-off.
The tactical pause follows Toscafund's non-binding proposal made in May 2026 at 250 pence per share, a valuation that equates to roughly roughly "
Separately, the market also reacted to the closing of a major asset sale. Blue Owl Capital, together with Moor Park Capital Partners, completed the purchase of a portfolio of 12 acute-care hospitals operated by Spire in the UK, for about approximately
The financing for that transaction was provided via a new secured term loan arranged by Standard Chartered Bank, Natixis, and Cr dit Agricole CIB, and the acquisition was executed through Blue Owl's European Net Lease Fund. Market participants viewed the deal as confirming the embedded real estate value in Spire's hospital estate, a point that in turn strengthened the underlying case for Toscafund's approach to the company.
These company-level developments came against a broader UK market that was under pressure. The FTSE 250, of which Spire is a constituent, traded cautiously after a heavy session the day before as geopolitical tensions in the Middle East intensified and oil prices rose. Investors remained sensitive to the potential for renewed conflict risks to feed through to inflation and to weigh on European equities more widely.
In this environment the relative resilience in Spire's share price reflects the dominance of idiosyncratic M&A activity in steering near-term price movement. The combination of a live, repeatedly extended takeover timetable, a 250p per share proposal that is materially above prevailing levels, and the completion of a high-profile hospital portfolio sale that underscores asset quality gave investors a reason to focus on the stock despite uncertain macro conditions.
Summary - Spire rose after Toscafund's takeover deadline was extended to August 6, 2026 and following the completion of a c.